文献速递腹部介入CTUS

聚焦超声联合微泡治疗接受化疗的结直肠癌肝转移患者

Treatment of Liver Metastases With Focused Ultrasound and Microbubbles in Patients With Colorectal Cancer Receiving Chemotherapy.
PubMed 文献 · Ultrasound Med Biol · 2023-06-17

纳入17例结直肠癌肝转移患者,每例选两个病灶随机分别接受聚焦超声联合微泡或对照,化疗后行聚焦超声(频率1.67 MHz、机械指数0.5)联合SonoVue微泡治疗35分钟,计划4个周期;结果显示该方案安全可行,但未证实疗效,病灶间疗效差异大,仅呈FUS+MBs组体积缩小更大的趋势。

要点

  • 聚焦超声联合微泡在所用参数下安全,但本试验未证实其提高化疗疗效。
  • 病灶间治疗反应差异大,仅化疗病灶亦见混合反应,结果解释困难。
  • FUS+MBs组病灶体积缩小幅度有大于对照组的趋势,但未达统计学结论。

核心结论

  • 聚焦超声联合微泡是安全、可行且可用的策略,但本试验未证实其治疗效应;建议开展标准化方案的多中心试验。

研究设计与样本

  • 纳入17例结直肠癌肝转移患者,每例选两个肝病灶随机分别接受FUS+MBs或对照;化疗(FOLFIRI或FOLFOXIRI)后行FUS(频率1.67 MHz、机械指数0.5、脉冲重复频率0.33 Hz、33次振荡、占空比0.2%-0.4%)联合SonoVue微泡35分钟,微泡按3.5分钟间隔静脉注射共9次,计划4个周期;以CT图像评估病灶大小变化。

临床应用与阅片要点

  • 作者认为FUS+MBs联合是安全、可行且可用的改善化疗效果策略。
  • 作者指出本试验未证实治疗效应,病灶间异质性和混合反应使结果难以解释。
  • 作者建议开展标准化方案的多中心试验。

局限性

  • 治疗反应在病灶间存在相当大的差异,仅接受化疗的病灶也出现混合反应。
  • 对化疗的混合反应和病灶异质性使结果难以解释。
  • 本试验未证实治疗效应。
  • 作者建议开展标准化方案的多中心试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Pre-clinical trials have obtained promising results that focused ultrasound (FUS) combined with microbubbles (MBs) increases tumor uptake and the therapeutic effect of drugs. The aims of the study described here were to investigate whether FUS and MBs could improve the effect of chemotherapy in patients with liver metastases from colorectal cancer and to investigate the safety and feasibility of using FUS + MBs.

METHODS: We included 17 patients with liver metastases from colorectal cancer, selected two lesions in each patient's liver and randomized the lesions for, respectively, treatment with FUS + MBs or control. After chemotherapy (FOLFIRI or FOLFOXIRI), the lesions were treated with FUS (frequency = 1.67 MHz, mechanical index = 0.5, pulse repetition frequency = 0.33 Hz, 33 oscillations, duty cycle = 0.2%-0.4% and MBs (SonoVue) for 35 min). Nine boluses of MBs were injected intravenously at 3.5 min intervals. Patients were scheduled for four cycles of treatment. Changes in the size of metastases were determined from computed tomography images.

RESULTS: Treatment with FUS + MBs is safe at the settings used. There was considerable variation in treatment response between lesions and mixed response between lesions receiving only chemotherapy. There is a tendency toward larger-volume reduction in lesions treated with FUS + MBs compared with control lesions, but a mixed response to chemotherapy and lesion heterogeneity make it difficult to interpret the results.

CONCLUSION: The combination of FUS and MBs is a safe, feasible and available strategy for improving the effect of chemotherapy in cancer patients. Therapeutic effect was not demonstrated in this trial. Multicenter trials with standardized protocols should be performed.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Haram, Hansen, Bouget, et al. Treatment of Liver Metastases With Focused Ultrasound and Microbubbles in Patients With Colorectal Cancer Receiving Chemotherapy. Ultrasound Med Biol. 2023. PMID: 37336691. doi:10.1016/j.ultrasmedbio.2023.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。